|
2024
|
P/S
|
Pharmaceutical preparations and substances, namely, peppermint oil and peppermint oil capsules fo... |
|
|
Invention
|
Antibody variants.
The present invention relates to antibodies which bind to TNFα and exhibit mo... |
|
|
Invention
|
Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal ... |
|
2023
|
P/S
|
Pharmaceutical preparations and substances, namely, preparations and substances for treating dise... |
|
|
Invention
|
Preparation of solid dosage forms comprising antibodies by solutions/suspension layering.
The pr... |
|
|
Invention
|
Topical treatment of inflammatory bowel disease using antibodies and fragments thereof.
The pres... |
|
2022
|
Invention
|
Anti-tnf-alpha-antibodies and functional fragments thereof.
The present invention relates to ant... |
|
|
Invention
|
Antibody variants.
The present invention relates to antibodies which bind to TNFα and comprise a... |
|
|
Invention
|
Anti-tnf-alpha-antibodies and functional fragments thereof. The present invention relates to anti... |
|
|
P/S
|
Pharmaceutical preparations, namely, for the diagnosis, prevention and/or treatment of gastrointe... |
|
2021
|
Invention
|
Modified release coated capsules. Herein described is a modified release coated capsule and a pro... |
|
|
P/S
|
Pharmaceutical preparations, namely, preparations for the prevention and treatment of gastrointes... |
|
2020
|
Invention
|
Delayed release drug formulation. In a delayed release formulation comprising a core containing a... |
|
|
P/S
|
Pharmaceutical and veterinary preparations and substances; preparations and substances for treati... |
|
2019
|
Invention
|
Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis usin... |
|
|
Invention
|
Method of producing a delayed release drug formulation.
A method produces a coatable core for a ... |
|
|
Invention
|
Colonic drug delivery formulation.
A delayed release drug formulation for oral administration de... |
|
|
Invention
|
Coatable core for a modified release drug formulation.
A method produces a coatable core for a m... |
|
|
Invention
|
Colonic drug delivery formulation.
A delayed release drug formulation contains a core containing... |
|
|
Invention
|
Colonic drug delivery formulation. A delayed release drug formulation for oral administration to ... |
|
|
Invention
|
Delayed release drug formulation comprising an outerlayer with an enzymaticyally degradable polym... |
|
|
Invention
|
Colonic drug delivery formulation. In a delayed release drug formulation comprising a core contai... |
|
|
Invention
|
Solid composition comprising mesalazine. A method of producing a coatable core for a modified rel... |
|
|
Invention
|
A process for manufacturing reducing sugar-free 5-asa tablet cores. A process for manufacturing 5... |
|
|
P/S
|
Education; training; entertainment; sporting and cultural
activities; organizing and conducting ... |
|
2018
|
Invention
|
Preparation of solid dosage forms comprising antibodies by solution/suspension layering. The pres... |
|
|
Invention
|
Antibody variants. The present invention relates to antibodies which bind to TNFα and comprise a ... |
|
|
Invention
|
Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and ... |
|
|
Invention
|
Antibody variants. The present invention relates to antibodies which bind to TNFα and exhibit mod... |
|
|
Invention
|
Preparation of sustained release solid dosage forms comprising antibodies by spray drying. The pr... |
|
|
Invention
|
Antibody variants. The present invention relates to antibodies which bind to TNF.alpha. and exhib... |
|
|
Invention
|
Antibody variants. The present invention relates to antibodies which bind to TNF.alpha. and compr... |
|
|
Invention
|
Antibody variants. The present invention relates to antibodies which bind to TNFa and exhibit mod... |
|
|
Invention
|
Use of anti-tnfα antibodies for treating wounds. The present invention relates to an antibody com... |
|
|
P/S
|
Pharmaceutical products, namely, for the diagnosis, prevention and/or treatment of gastrointestin... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical products,
namely, for the diagnosis, prevention and/... |
|
|
P/S
|
Préparations pharmaceutiques pour le diagnostic, la prévention et le traitement d'affections et t... |
|
|
P/S
|
Appareils et instruments scientifiques et d'enseignement, nommément applications mobiles téléchar... |
|
|
P/S
|
Scientific and teaching apparatus and instruments; apparatus
for recording, transmission or repr... |
|
|
Invention
|
Topical treatment of inflammatory bowel disease using antibodies and fragments thereof. The prese... |
|
|
Invention
|
Delayed release pharmaceutical formulation and methods of making and using same. The present inve... |
|
2017
|
P/S
|
Pharmaceutical and veterinary products, particularly for
diagnosis, prevention and/or treatment ... |
|
|
P/S
|
Pharmaceuticals and veterinary preparations, namely for diagnosing, preventing and/or treating ga... |
|
|
Invention
|
Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive ... |
|
|
P/S
|
Pharmaceutical preparations, in particular for the
diagnosis, prevention and/or treatment of gas... |
|
|
P/S
|
Pharmaceutical and veterinary preparations, namely, for diagnosis, prevention and treatment of ga... |
|
|
P/S
|
Pharmaceutical and veterinary preparations, namely for
diagnosis, prevention and/or treatment of... |
|
|
Invention
|
Anti-tnf-α-antibodies and functional fragments thereof. The present invention relates to antibody... |
|
|
P/S
|
Pharmaceutical and veterinary preparations, namely preparations for the diagnosis, prevention and... |
|
|
P/S
|
Pharmaceutical preparations, namely for the diagnosis, prevention and treatment of gastrointestin... |
|
|
P/S
|
Pharmaceutical preparations and substances namely tablets, capsules and liquids for treating and ... |
|
|
P/S
|
Pharmaceutical preparations and substances namely peppermint oil and peppermint oil capsules for ... |
|
|
P/S
|
Pharmaceutical preparations, for the diagnosis, prevention and treatment of gastrointestinal diso... |
|
|
P/S
|
Pharmaceutical preparations, namely for the diagnosis,
prevention and/or treatment of gastrointe... |
|
2016
|
P/S
|
Pharmaceutical preparations, namely for the diagnosis, prevention and/or treatment of gastrointes... |
|
|
Invention
|
Microgel particles containing nanotubes loaded with an active pharmaceutical ingredient. The pres... |
|
2015
|
P/S
|
Scientific and teaching apparatus and instruments; Apparatus for recording, transmission or repro... |
|
|
P/S
|
Pharmaceutical preparations, in particular for the diagnosis, prevention and/or treatment of gast... |
|
2014
|
P/S
|
Preparations and substances for the treatment of
gastro-intestinal diseases and disorders. |
|
2013
|
P/S
|
Pharmaceutical preparations, namely preparations for the prevention and treatment of gastrointest... |
|
|
P/S
|
Pharmaceutical preparations, namely preparations for the
prevention and treatment of gastrointes... |
